BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
99 results:

  • 1. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Acute myeloid leukemia with LRRFIP1::fgfr1 rearrangement and a complex karyotype.
    Qian YW; Wang ES; Sait SJ; Glenn ST
    Cancer Genet; 2023 Nov; 278-279():50-54. PubMed ID: 37597337
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myeloid/lymphoid neoplasm with eosinophilia and BCR/fgfr1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
    Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
    J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.
    Lazo De La Vega L; Comeau H; Sallan S; Al-Ibraheemi A; Gupta H; Li YY; Tsai HK; Kang W; Ward A; Church AJ; Kim A; Pinto NR; Macy ME; Maese LD; Sabnis AJ; Cherniack AD; Lindeman NI; Anderson ME; Cooney TM; Yeo KK; Reaman GH; DuBois SG; Collins NB; Johnson BE; Janeway KA; Forrest SJ
    JCO Precis Oncol; 2022 Nov; 6():e2200390. PubMed ID: 36446043
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bioinformatic Analyses of Broad H3K79me2 Domains in Different leukemia Cell Line Data Sets.
    Sharma P; Sattarifard H; Fatemiyan N; Lakowski TM; Davie JR
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139405
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Pax-5a gene analysis approach enabled by selective digestion with lambda exonuclease.
    Xu L; Zhao W; Pu J; Wang S; Liu S; Li H; Yu R
    Anal Methods; 2022 Jun; 14(24):2415-2422. PubMed ID: 35670541
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-fgfr1 rearrangement: A case report and literature review.
    Washburn E; Bayerl MG; Ketterling RP; Malysz J
    Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
    Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
    Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.
    Shallis RM; Siddon AJ; Zeidan AM
    Curr Hematol Malig Rep; 2021 Jun; 16(3):276-285. PubMed ID: 33890194
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Application of transcriptome sequencing and fusion genes analysis in the diagnosis of myeloid leukemia with normal karyotype].
    Jiang M; Zhou YR; Zhan Y; Zhang HQ; Zhang Q; Guo Y; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):939-944. PubMed ID: 33789375
    [No Abstract]    [Full Text] [Related]  

  • 13. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Characteristic of 8p11 Myeloproliferative Syndrome with Rare Phenotype].
    Xue S; Xu HX; Zhang YP; Liu FH; Lu YY; Li F; Wang YP; Wang CC; Jia XP; Wang JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):181-187. PubMed ID: 33554816
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or fgfr1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
    Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
    Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.
    Bornhauser B; Cario G; Rinaldi A; Risch T; Rodriguez Martinez V; Schütte M; Warnatz HJ; Scheidegger N; Mirkowska P; Temperli M; Möller C; Schumich A; Dworzak M; Attarbaschi A; Brüggemann M; Ritgen M; Mejstrikova E; Hofmann A; Buldini B; Scarparo P; Basso G; Maglia O; Gaipa G; Skoblyn TL; Te Kronnie G; Vendramini E; Panzer-Grümayer R; Barz MJ; Marovca B; Hauri-Hohl M; Niggli F; Eckert C; Schrappe M; Stanulla M; Zimmermann M; Wollscheid B; Yaspo ML; Bourquin JP
    Blood Adv; 2020 Sep; 4(17):4052-4064. PubMed ID: 32853382
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
    Snider JS; Znoyko I; Lindsey KG; Morse J; Baughn LB; Hoppman NL; Pitel BA; Pearce KE; Schandl CA; Wolff DJ
    Cancer Genet; 2020 Aug; 246-247():44-47. PubMed ID: 32827877
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes.
    Di Fede E; Massa V; Augello B; Squeo G; Scarano E; Perri AM; Fischetto R; Causio FA; Zampino G; Piccione M; Curridori E; Mazza T; Castellana S; Larizza L; Ghelma F; Colombo EA; Gandini MC; Castori M; Merla G; Milani D; Gervasini C
    Eur J Hum Genet; 2021 Jan; 29(1):88-98. PubMed ID: 32641752
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circulating intranuclear proteins may play a role in development of disseminated intravascular coagulation in individuals with acute leukemia.
    Harada-Shirado K; Wang X; Mori H; Fukatsu M; Takahashi H; Shichishima-Nakamura A; Kimura S; Ohkawara H; Yamada S; Ito T; Ikezoe T
    Int J Hematol; 2020 Mar; 111(3):378-387. PubMed ID: 31848990
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.